Research and development leader to address UT students

October 31, 2014 | Research, UToday, Pharmacy and Pharmaceutical Sciences
By Aimee Portala

Dr. Jaume Pons, chief scientific officer and senior vice president of Rinat, a research and development division of Pfizer, will speak to students interested in a career in the bioscience industry.



The event, presented by the Graduate Student Association and the Department of Biological Sciences, will take place Tuesday, Nov. 4, at 10 a.m. in Student Union Room 2582. All are welcome.

Rinat, located in San Francisco, is the biotechnology unit of Pfizer, which is one of the world’s leading pharmaceutical companies.

Pons is responsible for portfolio delivery from idea to clinical development. He also serves as chief technology officer, focusing on antibody technologies, and is a member of the Pfizer Worldwide Research and Development leadership team. Pons previously created and led Rinat’s protein engineering group and has invented several antibodies that are now in late-stage clinical development.

Under his leadership, Rinat continues to advance Pfizer’s growing capabilities in generating therapeutic antibodies.

Pons earned his PhD in molecular and cell biology at the Institute on Fundamental Biology in Barcelona, Spain, and his bachelor of science degree in biochemistry from Autonoma University of Barcelona. He conducted his postdoctoral studies in antibody engineering at the University of California at Berkeley.

Students interested in meeting Pons in a smaller group session may contact Jeff Zahratka at This is a first-come, first-served opportunity.

Click to access the login or register cheese